INDIGO Biosciences Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 21
Employees
  • Latest Deal Type
  • Series B1
  • Latest Deal Amount
  • $1.14M
Latest Deal Amount
  • Investors
  • 9

INDIGO Biosciences General Information

Description

Provider of nuclear receptor assay kits and screening services designed to reduce time, cost and risk in the drug discovery process. The company's services provide long-term cryopreservation of cells for shipping and storage, thus offering the convenience of readily available robust cell-based reporter assays for on-demand use, enabling clients within the pharmaceutical and biotechnology industries to screen small molecule compounds against functional human and non-human nuclear receptors.receptors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Drug Delivery
Primary Office
  • 3006 Research Drive
  • Suite A1
  • State College, PA 16801
  • United States
+1 (814) 000-0000

INDIGO Biosciences Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

INDIGO Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B1) 01-Oct-2018 $1.14M 00.000 00.000 Completed Generating Revenue
4. Angel (individual) 25-Jan-2018 00.000 Completed Generating Revenue
3. Later Stage VC (Series B) 15-May-2017 00.00 00.000 00.00 Completed Generating Revenue
2. Later Stage VC (Series A2) 01-Jan-2014 $3.68M $3.93M 00.00 Completed Generating Revenue
1. Early Stage VC (Series A) 09-Dec-2008 $250K $250K Completed Generating Revenue
To view INDIGO Biosciences’s complete valuation and funding history, request access »

INDIGO Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-2 0,000,000 00.000000 00 00 00 00 00.000
To view INDIGO Biosciences’s complete cap table history, request access »

INDIGO Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of nuclear receptor assay kits and screening services designed to reduce time, cost and risk in the drug discov
Biotechnology
State College, PA
21 As of 2020
00.000
0.000 0000-00-00
00000000000 00.000

00000000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conseq
0000000000 000000000
Fremont, CA
000 As of 0000
000.00
000000&0 000.00

000000 (

ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mo
0000000000000
Heidelberg, Germany
00 As of 0000
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

INDIGO Biosciences Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DiscoverX Formerly VC-backed Fremont, CA 000 000.00 000000&0 000.00
000000 (0000000000 Venture Capital-Backed Heidelberg, Germany 00 000.00 000000000000 000.00
You’re viewing 2 of 2 competitors. Get the full list »

INDIGO Biosciences Executive Team (7)

Name Title Board Seat Contact Info
Fred Marroni President, Chief Executive Officer & Board Member
Robert Culhane Chief Financial Officer
Bruce Sherf Chief Technology Officer
John Vanden Heuvel Ph.D Co-Founder, Chief Scientific Officer & Board Member
You’re viewing 4 of 7 executive team members. Get the full list »

INDIGO Biosciences Board Members (11)

Name Representing Role Since
Brad Harmon INDIGO Biosciences Board Member 000 0000
Christopher Novak Self Board Member 000 0000
Craig Karasin Self Board Observer & Advisor 000 0000
Donald Belt Allied Growth Strategies & Management Board Member 000 0000
Fred Marroni INDIGO Biosciences President, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

INDIGO Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

INDIGO Biosciences Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Keiretsu Capital Venture Capital Minority 000 0000 000000 0
Broad Street Angels Angel Group Minority 000 0000 000000 0
Angels + Life.Sci Investors Network Angel Group Minority 000 0000 000000 0
Keiretsu Forum Venture Capital Minority 000 0000 000000 0
Allied Growth Strategies & Management PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »